2023 Q2 Form 10-Q Financial Statement

#000095017023018312 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $133.5M $135.4M $120.8M
YoY Change 8.64% 12.02% 23.65%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $46.42M $62.70M $44.55M
YoY Change -20.28% 40.74% -8.24%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.566M $4.078M $3.238M
YoY Change 19.03% 25.94% 12.0%
% of Gross Profit
Operating Expenses $109.4M $62.70M $87.06M
YoY Change 87.96% -27.98% 79.31%
Operating Profit
YoY Change
Interest Expense -$16.22M -$16.78M $59.00K
YoY Change 114.49% -28544.07% -99.17%
% of Operating Profit
Other Income/Expense, Net $10.48M $11.06M $10.55M
YoY Change 5.64% 4.85% 27.66%
Pretax Income $7.813M $11.61M $34.95M
YoY Change -50.51% -66.79% 4.67%
Income Tax $1.790M $2.916M $8.166M
% Of Pretax Income 22.91% 25.13% 23.37%
Net Earnings $6.023M $8.689M $26.78M
YoY Change -49.73% -67.56% 4.94%
Net Earnings / Revenue 4.51% 6.42% 22.16%
Basic Earnings Per Share $0.64 $0.93 $2.81
Diluted Earnings Per Share $0.63 $0.90 $2.67
COMMON SHARES
Basic Shares Outstanding 9.643M 9.523M 9.533M
Diluted Shares Outstanding 9.566M 9.622M 10.02M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.33M $7.108M $17.64M
YoY Change 30.3% -59.69% 144.93%
Cash & Equivalents $141.5M $134.3M $156.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $10.33M $7.108M $17.64M
YoY Change 30.3% -59.69% 144.93%
LONG-TERM ASSETS
Property, Plant & Equipment $49.69M $15.00M $41.12M
YoY Change 287.92% -63.53% 1.04%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $20.30M $22.49M
YoY Change
Other Assets $146.4M $141.9M $157.0M
YoY Change -11.05% -9.65% 68.11%
Total Long-Term Assets $1.713B $1.694B $1.480B
YoY Change 11.25% 14.46% 35.65%
TOTAL ASSETS
Total Short-Term Assets $10.33M $7.108M $17.64M
Total Long-Term Assets $1.713B $1.694B $1.480B
Total Assets $1.724B $1.701B $1.498B
YoY Change 11.35% 13.58% 36.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.03M $26.05M $46.30M
YoY Change -21.63% -43.73% 13.21%
Accrued Expenses $37.15M $36.91M $30.25M
YoY Change 19.39% 22.0% 1.86%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $64.18M $62.96M $76.55M
YoY Change -2.18% -17.76% 8.43%
LONG-TERM LIABILITIES
Long-Term Debt $1.338B $1.321B $1.122B
YoY Change 13.02% 17.74% 50.86%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.338B $1.321B $1.122B
YoY Change 13.02% 17.74% 50.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $64.18M $62.96M $76.55M
Total Long-Term Liabilities $1.338B $1.321B $1.122B
Total Liabilities $1.402B $1.384B $1.199B
YoY Change 12.23% 15.47% 47.16%
SHAREHOLDERS EQUITY
Retained Earnings $354.3M $351.3M
YoY Change 4.54%
Common Stock $117.7M $115.9M
YoY Change 7.18%
Preferred Stock
YoY Change
Treasury Stock (at cost) $150.1M $150.1M
YoY Change 0.0%
Treasury Stock Shares $4.807M
Shareholders Equity $321.5M $316.7M $298.7M
YoY Change
Total Liabilities & Shareholders Equity $1.724B $1.701B $1.498B
YoY Change 11.35% 13.58% 36.36%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $6.023M $8.689M $26.78M
YoY Change -49.73% -67.56% 4.94%
Depreciation, Depletion And Amortization $3.566M $4.078M $3.238M
YoY Change 19.03% 25.94% 12.0%
Cash From Operating Activities $62.08M $52.65M $45.79M
YoY Change -2.45% 14.99% 30.78%
INVESTING ACTIVITIES
Capital Expenditures $3.047M $1.647M $1.126M
YoY Change -226.43% 46.27% 173.97%
Acquisitions
YoY Change
Other Investing Activities -$61.53M -$16.82M -$47.59M
YoY Change -44.14% -64.65% -622.93%
Cash From Investing Activities -$64.57M -$20.20M -$49.36M
YoY Change -42.63% -59.07% -432.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $9.031M
YoY Change -23.69%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.674M -29.96M 10.93M
YoY Change -78.55% -374.05% -130.8%
NET CHANGE
Cash From Operating Activities 62.08M 52.65M 45.79M
Cash From Investing Activities -64.57M -20.20M -49.36M
Cash From Financing Activities 9.674M -29.96M 10.93M
Net Change In Cash 7.176M 2.487M 7.365M
YoY Change -287.66% -66.23% -48.72%
FREE CASH FLOW
Cash From Operating Activities $62.08M $52.65M $45.79M
Capital Expenditures $3.047M $1.647M $1.126M
Free Cash Flow $59.03M $51.00M $44.66M
YoY Change -10.62% 14.2% 29.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001519401
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
1321462000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1345847000
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-35477
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Regional Management Corp.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
57-0847115
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
979 Batesville Road
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite B
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Greer
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
SC
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
29651
CY2023Q1 dei City Area Code
CityAreaCode
864
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
448-7000
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2023Q1 dei Trading Symbol
TradingSymbol
RM
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9643472
CY2023Q1 us-gaap Cash
Cash
7108000
CY2022Q4 us-gaap Cash
Cash
3873000
CY2023Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1676230000
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1699393000
CY2023Q1 us-gaap Unearned Premiums
UnearnedPremiums
49126000
CY2022Q4 us-gaap Unearned Premiums
UnearnedPremiums
51008000
CY2023Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
183800000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
178800000
CY2023Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1443304000
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1469585000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
127178000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
127926000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
34507000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
34521000
CY2023Q1 us-gaap Debt Securities Available For Sale Restricted
DebtSecuritiesAvailableForSaleRestricted
22489000
CY2022Q4 us-gaap Debt Securities Available For Sale Restricted
DebtSecuritiesAvailableForSaleRestricted
20416000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14999000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14526000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
14690000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13810000
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
12972000
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
12122000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
36905000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
36712000
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
26054000
CY2023Q1 us-gaap Other Assets
OtherAssets
23867000
CY2022Q4 us-gaap Other Assets
OtherAssets
28208000
CY2023Q1 us-gaap Assets
Assets
1701114000
CY2022Q4 us-gaap Assets
Assets
1724987000
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1329677000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1355359000
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
8215000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
9512000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
33795000
CY2023Q1 us-gaap Liabilities
Liabilities
1384421000
CY2022Q4 us-gaap Liabilities
Liabilities
1416354000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14385000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9578000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14330000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9523000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1438000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1433000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
114452000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
112384000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
351324000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
345545000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-378000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-586000
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
4807000
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4807000
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
150143000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
150143000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
316693000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
308633000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1701114000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1724987000
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
120407000
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
107631000
CY2023Q1 us-gaap Insurance Services Revenue
InsuranceServicesRevenue
10959000
CY2022Q1 us-gaap Insurance Services Revenue
InsuranceServicesRevenue
10544000
CY2023Q1 us-gaap Other Income
OtherIncome
4012000
CY2022Q1 us-gaap Other Income
OtherIncome
2673000
CY2023Q1 us-gaap Revenues
Revenues
135378000
CY2022Q1 us-gaap Revenues
Revenues
120848000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
47668000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
30858000
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
38597000
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
35654000
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
6288000
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
5808000
CY2023Q1 us-gaap Marketing Expense
MarketingExpense
3379000
CY2022Q1 us-gaap Marketing Expense
MarketingExpense
3091000
CY2023Q1 us-gaap Other Expenses
OtherExpenses
11059000
CY2022Q1 us-gaap Other Expenses
OtherExpenses
10547000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
59323000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55100000
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-16782000
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
59000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11605000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
34949000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2916000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8166000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
8689000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
26783000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.81
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.90
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.67
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9325000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9533000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9622000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10022000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
263000
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
263000
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
55000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
208000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8897000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26783000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
308633000
CY2023Q1 us-gaap Dividends Cash
DividendsCash
2910000
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
31000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2104000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
8689000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
208000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
316693000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
282736000
CY2022Q1 us-gaap Dividends Cash
DividendsCash
3010000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9031000
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
848000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2106000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
26783000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
298742000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
8689000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
26783000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
47668000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
30858000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4078000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3238000
CY2023Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
3778000
CY2022Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
3905000
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-113000
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2104000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2106000
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
10158000
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-935000
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
327000
CY2023Q1 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-1882000
CY2022Q1 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-762000
CY2023Q1 rm Increase Decrease In Lease Assets
IncreaseDecreaseInLeaseAssets
-14000
CY2022Q1 rm Increase Decrease In Lease Assets
IncreaseDecreaseInLeaseAssets
-634000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4426000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8041000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2891000
CY2023Q1 rm Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
193000
CY2022Q1 rm Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-449000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
52649000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
45787000
CY2023Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
311484000
CY2022Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
326329000
CY2023Q1 us-gaap Proceeds From Collection Of Finance Receivables
ProceedsFromCollectionOfFinanceReceivables
296564000
CY2022Q1 us-gaap Proceeds From Collection Of Finance Receivables
ProceedsFromCollectionOfFinanceReceivables
278742000
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1733000
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
642000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1647000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1126000
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1900000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20200000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-49355000
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
408683000
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
437815000
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
434221000
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
552118000
CY2023Q1 us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
0
CY2022Q1 us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
250000000
CY2022Q1 us-gaap Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
109228000
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1160000
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2657000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
145000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
828000
CY2023Q1 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
3119000
CY2022Q1 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
3020000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9031000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29962000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10933000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2487000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7365000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131799000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
149189000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
134286000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156554000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
14750000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
8616000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
15000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2316000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2794000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2023000
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1246000
CY2023Q1 rm Dividends Payable Current And Noncurrent Net
DividendsPayableCurrentAndNoncurrentNet
-209000
CY2022Q1 rm Dividends Payable Current And Noncurrent Net
DividendsPayableCurrentAndNoncurrentNet
-10000
CY2023Q1 us-gaap Cash
Cash
7108000
CY2022Q4 us-gaap Cash
Cash
3873000
CY2022Q1 us-gaap Cash
Cash
17635000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
127178000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
127926000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
138919000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
134286000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131799000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156554000
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:13.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Note 1. Nature of Business</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Regional Management Corp. (the “</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Company</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">”) was incorporated and began operations in 1987. The Company is engaged in the consumer finance business, offering small loans, large loans, and related payment and collateral protection insurance products. The Company formerly offered retail loans but ceased accepting applications for retail loan products effective November 2022. The Company continues to own and service its existing portfolio of retail loans. As of March 31, 2023, the Company operated under the name “Regional Finance” online and in branch locations in </span><span style="font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">19</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> states across the United States.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">The Company’s small loan portfolio is comprised of branch small loan receivables and convenience check receivables. Branch small loan receivables are direct loans to customers and are secured by non-essential household goods and, in some instances, an automobile. Convenience checks are direct loans originated by mailing checks to customers based on a pre-screening process that includes a review of the prospective customer’s credit profile provided by national credit reporting bureaus or data aggregators. A recipient of a convenience check is able to enter into a loan by endorsing and depositing or cashing the check. Large loan receivables are direct loans to customers, some of which are convenience check receivables and the vast majority of which are secured by non-essential household goods, automobiles, and/or other vehicles. Retail loan receivables consist principally of retail installment sales contracts collateralized by the purchased furniture, appliances, and other retail items and are initiated by and purchased from retailers, subject to the Company’s credit approval.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">The Company’s loan volume and contractual delinquency follow seasonal trends. Demand for the Company’s small and large loans is typically highest during the second, third, and fourth quarters, which the Company believes is largely due to customers borrowing money for vacation, back-to-school, and holiday spending. Loan demand has generally been the lowest during the first quarter, which the Company believes is largely due to the timing of income tax refunds. Delinquencies generally reach their lowest point in the first half of the year and rise in the second half of the year. Changes in quarterly growth or liquidation could result in larger allowance for credit loss releases in periods of portfolio liquidation, and larger provisions for credit losses in periods of portfolio growth. Consequently, the Company experiences seasonal fluctuations in its operating results. However, changes in macroeconomic factors, including inflation, rising interest rates, and geopolitical conflict, have impacted the Company’s typical seasonal trends for loan volume and delinquency.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p>
CY2023Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
19
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;font-style:italic;min-width:fit-content;">Use of estimates:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and disclosure of contingent assets and liabilities for the periods indicated in the financial statements. Actual results could differ from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Estimates that are susceptible to change relate to the determination of the allowance for credit losses, the valuation of deferred tax assets and liabilities, and the fair value of financial instruments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p>
CY2023Q1 rm Financing Receivable Credit Losses Two Years Before Latest Fiscal Year
FinancingReceivableCreditLossesTwoYearsBeforeLatestFiscalYear
16803000
CY2023Q1 rm Financing Receivable Credit Losses Three Years Before Latest Fiscal Year
FinancingReceivableCreditLossesThreeYearsBeforeLatestFiscalYear
1996000
CY2023Q1 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
15100000
CY2023Q1 rm Threshold Period Past Due For Write Off Of Financing Receivables
ThresholdPeriodPastDueForWriteOffOfFinancingReceivables
P180D
CY2023Q1 rm Bankruptcy Threshold Period Past Due For Write Off Of Financing Receivables
BankruptcyThresholdPeriodPastDueForWriteOffOfFinancingReceivables
P60D
CY2023Q1 rm Finance Receivables Income Recognition Contractual Delinquent Period
FinanceReceivablesIncomeRecognitionContractualDelinquentPeriod
P90D
CY2023Q1 us-gaap Financing Receivable Threshold Period Past Due Writeoff
FinancingReceivableThresholdPeriodPastDueWriteoff
P90D
CY2023Q1 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
1893000
CY2023Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1676230000
CY2023Q1 rm Financing Receivable Current Period Credit Losses In Current Fiscal Year
FinancingReceivableCurrentPeriodCreditLossesInCurrentFiscalYear
22000
CY2023Q1 rm Financing Receivable Credit Losses Before Latest Fiscal Year
FinancingReceivableCreditLossesBeforeLatestFiscalYear
25160000
CY2023Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1676230000
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1699393000
CY2023Q1 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
14500000
CY2022Q4 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
16000000.0
CY2023Q1 rm Number Of Fico Band Categories
NumberOfFICOBandCategories
6
CY2023Q1 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
293663000
CY2023Q1 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
1016654000
CY2023Q1 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
291953000
CY2023Q1 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
56967000
CY2023Q1 rm Financing Receivable Credit Losses Four Years Before Latest Fiscal Year
FinancingReceivableCreditLossesFourYearsBeforeLatestFiscalYear
554000
CY2023Q1 rm Financing Receivable Credit Losses More Than Five Years Before Latest Fiscal Year
FinancingReceivableCreditLossesMoreThanFiveYearsBeforeLatestFiscalYear
74000
CY2023Q1 rm Loans And Leases Receivable Current Period Credit Losses
LoansAndLeasesReceivableCurrentPeriodCreditLosses
44609000
CY2022Q4 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
1223479000
CY2022Q4 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
376467000
CY2022Q4 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
74424000
CY2022Q4 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
22270000
CY2022Q4 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
1779000
CY2022Q4 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
974000
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1699393000
CY2023Q1 us-gaap Financing Receivable Percent Past Due1
FinancingReceivablePercentPastDue1
0.072
CY2023Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1676230000
CY2023Q1 rm Finance Receivable Net Percent
FinanceReceivableNetPercent
1.000
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
71631000
CY2023Q1 rm Financing Receivable Recorded Investment Nonaccrual Status Percent
FinancingReceivableRecordedInvestmentNonaccrualStatusPercent
0.043
CY2022Q4 us-gaap Financing Receivable Percent Past Due1
FinancingReceivablePercentPastDue1
0.071
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1699393000
CY2022Q4 rm Finance Receivable Net Percent
FinanceReceivableNetPercent
1.000
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
60061000
CY2022Q4 rm Financing Receivable Recorded Investment Nonaccrual Status Percent
FinancingReceivableRecordedInvestmentNonaccrualStatusPercent
0.035
CY2023Q1 us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
4700000
CY2022Q1 us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
3700000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
178800000
CY2023Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
47668000
CY2023Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
44609000
CY2023Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
1941000
CY2023Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
183800000
CY2023Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1676230000
CY2023Q1 rm Allowance Percentage Of Finance Receivables
AllowancePercentageOfFinanceReceivables
0.110
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
159300000
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
30858000
CY2022Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
32780000
CY2022Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
1422000
CY2022Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
158800000
CY2022Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1446071000
CY2022Q1 rm Allowance Percentage Of Finance Receivables
AllowancePercentageOfFinanceReceivables
0.110
CY2023Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
10407000
CY2023Q1 rm Financing Receivable Modifications Percentage Of Net Financing Receivables
FinancingReceivableModificationsPercentageOfNetFinancingReceivables
0.006
CY2022Q1 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
5512000
CY2022Q1 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
466
CY2022Q1 rm Tdr Finance Receivables Defaulted
TDRFinanceReceivablesDefaulted
1696000
CY2023Q1 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
54000
CY2022Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
1529
CY2023Q1 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
100000
CY2022Q4 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
300000
CY2021Q4 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
6586000
CY2022Q1 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
10158000
CY2022Q1 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
16744000
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1329677000
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
8215000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
1321462000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1355359000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
9512000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1345847000
CY2023Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
580655000
CY2022Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
555117000
CY2021Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000.0
CY2021Q3 rm Increase Decrease In Authorized Amount Under Stock Repurchase Program
IncreaseDecreaseInAuthorizedAmountUnderStockRepurchaseProgram
20000000.0
CY2021Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000.0
CY2021Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000.0
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
945000
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
20000000.0
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
426000
CY2022Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
184000
CY2022Q1 rm Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Repurchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesRepurchased
49.00
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
9031000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2023Q1 rm Provision For Corporate Taxes
ProvisionForCorporateTaxes
2901000
CY2022Q1 rm Provision For Corporate Taxes
ProvisionForCorporateTaxes
8562000
CY2023Q1 rm Discrete Tax Benefits Deficiencies
DiscreteTaxBenefitsDeficiencies
15000
CY2022Q1 rm Discrete Tax Benefits Deficiencies
DiscreteTaxBenefitsDeficiencies
-396000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2916000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8166000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
8689000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
26783000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9325000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9533000
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
297000
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
489000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9622000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10022000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.81
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.90
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.67
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
527000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
23.07
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
527000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
23.07
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M6D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2403000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
475000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
22.32
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y4M24D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2389000
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2142000
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0

Files In Submission

Name View Source Status
rm-20230331_cal.xml Edgar Link unprocessable
rm-20230331_pre.xml Edgar Link unprocessable
0000950170-23-018312-index-headers.html Edgar Link pending
0000950170-23-018312-index.html Edgar Link pending
0000950170-23-018312.txt Edgar Link pending
0000950170-23-018312-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rm-20230331.htm Edgar Link pending
rm-20230331.xsd Edgar Link pending
rm-ex10_2.htm Edgar Link pending
rm-20230331_def.xml Edgar Link unprocessable
rm-20230331_lab.xml Edgar Link unprocessable
rm-20230331_htm.xml Edgar Link completed
rm-ex31_1.htm Edgar Link pending
rm-ex31_2.htm Edgar Link pending
rm-ex32_1.htm Edgar Link pending
Show.js Edgar Link pending